[11] Initially, small-scale pharmaceutical production took place in the Arany Sas (Golden Eagle) Pharmacy, which still operates today.

In compliance with the established international trends of the pharmaceutical industry in those days, the company produced herbal drugs, processed extracts from plants and manufactured synthetic products at a later date.

[13] In the 1970s, chemists at the Gedeon Richter Chemical Works in Budapest discovered the brain enhancing drug vinpocetine,[14] which continues to be used in treatment of cerebrovascular disorders.

Danco resolved to contracting Gedeon, because its prior attempts to find a US distributor failed due to "the politically volatile climate surrounding abortion in this country [the USA].

"[16] Facing a strong opposition from the US pro-life groups, Gedeon decided in 1997 to end its efforts to place mifepristone on the U.S. market.

[17] In May 2006 Gedeon Richter signed a development and supply agreement with the US-based company Repros Therapeutics to produce Proellex.

Barr paid Gedeon Richter a royalty for distributing the product in the U.S.[19] From July 2008 - April 2012, the company constructed a new manufacturing facility ($110 million) in Debrecen.

[24] As the new chief executive officer he appointed Gabor Orban, a former fund manager, government official and Bogsch's deputy since 2016.

[27] In February 2019, Gedeon Richter and Pantarhei Bioscience signed a license and supply agreement for the commercialization of a novel combined oral contraceptive.

[29] Richter's atypical antipsychotic, Reagila, containing the active ingredient cariprazine, was awarded the prize of Medicine of the Year 2019 by the Hungarian Society for Experimental and Clinical Pharmacology (MFT).

The board's chairman is Erik Bogsch, who had served as chief executive officer since 1992 and was succeeded by Gábor Orbán as CEO in November 2017.

[25][26] The board members are Gábor Gulácsi, János Csák, Dr. Ilona Hardy, Dr. György Bagdy, Csaba Lantos, Anett Pandurics, Bálint Szécsényi, Prof Dr Szilveszter E. Vizi, Dr.Kriszta Zolnay.